Royal Bank of Canada’s Oncolytics Biotech ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45K Sell
58,512
-8,598
-13% -$6.61K ﹤0.01% 5600
2025
Q1
$37K Buy
67,110
+3,428
+5% +$1.89K ﹤0.01% 5300
2024
Q4
$58K Sell
63,682
-10,864
-15% -$9.9K ﹤0.01% 5134
2024
Q3
$65K Buy
74,546
+12,279
+20% +$10.7K ﹤0.01% 5117
2024
Q2
$62K Buy
62,267
+1,234
+2% +$1.23K ﹤0.01% 5159
2024
Q1
$65K Buy
61,033
+6,108
+11% +$6.51K ﹤0.01% 4975
2023
Q4
$74K Sell
54,925
-804
-1% -$1.08K ﹤0.01% 5257
2023
Q3
$121K Buy
55,729
+2,524
+5% +$5.48K ﹤0.01% 4779
2023
Q2
$138K Sell
53,205
-451
-0.8% -$1.17K ﹤0.01% 4642
2023
Q1
$64K Buy
53,656
+7,222
+16% +$8.61K ﹤0.01% 5105
2022
Q4
$76K Sell
46,434
-2,406
-5% -$3.94K ﹤0.01% 5180
2022
Q3
$60K Buy
48,840
+5,153
+12% +$6.33K ﹤0.01% 5159
2022
Q2
$44K Sell
43,687
-1,359
-3% -$1.37K ﹤0.01% 5309
2022
Q1
$71K Buy
45,046
+3,570
+9% +$5.63K ﹤0.01% 5382
2021
Q4
$58K Buy
41,476
+921
+2% +$1.29K ﹤0.01% 5762
2021
Q3
$85K Buy
40,555
+3,903
+11% +$8.18K ﹤0.01% 5311
2021
Q2
$102K Buy
36,652
+9,271
+34% +$25.8K ﹤0.01% 5111
2021
Q1
$105K Sell
27,381
-8,201
-23% -$31.4K ﹤0.01% 4946
2020
Q4
$84K Buy
35,582
+4,963
+16% +$11.7K ﹤0.01% 4892
2020
Q3
$52K Sell
30,619
-25,864
-46% -$43.9K ﹤0.01% 4843
2020
Q2
$106K Buy
56,483
+1,507
+3% +$2.83K ﹤0.01% 4361
2020
Q1
$75K Sell
54,976
-5,189
-9% -$7.08K ﹤0.01% 4447
2019
Q4
$286K Buy
60,165
+48,610
+421% +$231K ﹤0.01% 3810
2019
Q3
$7K Buy
11,555
+251
+2% +$152 ﹤0.01% 5267
2019
Q2
$19K Sell
11,304
-3,911
-26% -$6.57K ﹤0.01% 4975
2019
Q1
$28K Buy
15,215
+7,324
+93% +$13.5K ﹤0.01% 4762
2018
Q4
$14K Sell
7,891
-4,371
-36% -$7.76K ﹤0.01% 4984
2018
Q3
$47K Buy
12,262
+3,363
+38% +$12.9K ﹤0.01% 4662
2018
Q2
$49K Buy
+8,899
New +$49K ﹤0.01% 4586